TRVI
Trevi Therapeutics Inc
NASDAQ: TRVI · HEALTHCARE · BIOTECHNOLOGY
$13.82
-0.14% today
Updated 2026-04-29
Market cap
$1.96B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$5 – $16
Volume
1.5M
Trevi Therapeutics Inc (TRVI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $4000.00 | $0.00 | $23000.00 | $39000.00 | $47000.00 | $50000.00 | $43000.00 | $123000.00 | $147000.00 | $132000.00 |
| Gross profit | $-4000.00 | $0.00 | $-23000.00 | $-39000.00 | $-47000.00 | $-50000.00 | $-43000.00 | $-123000.00 | $-147000.00 | $-132000.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — |
| R&D | $6.91M | $6.09M | $14.07M | $19.34M | $22.33M | $22.98M | $19.83M | $23.68M | $39.38M | $33.48M |
| SG&A | $1.66M | $2.14M | $4.34M | $7.31M | $10.16M | $9.49M | $10.07M | $10.24M | $12.15M | $15.85M |
| Operating income | $-8.63M | $-8.24M | $-18.41M | $-26.64M | $-32.49M | $-32.48M | $-29.91M | $-33.92M | $-51.52M | $-49.33M |
| Operating margin | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-8.62M | $-8.19M | $-18.39M | $-26.61M | $-32.44M | $-32.71M | $-29.86M | $-28.58M | $-47.79M | $-49.33M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-8.63M | $-8.19M | $-18.41M | $-26.64M | $-32.49M | $-32.76M | $-29.91M | $-28.71M | $-47.94M | $-49.46M |
| Interest expense | $0.00 | $3.34M | $174000.00 | $616000.00 | $456000.00 | $1.20M | $780000.00 | $391000.00 | $4000.00 | $0.00 |
| Income tax | $-8000.00 | $-26000.00 | $-124000.00 | $-18000.00 | $-18000.00 | $-21000.00 | $-36000.00 | $-32000.00 | $-30000.00 | — |
| Effective tax rate | 0.1% | 0.2% | 0.6% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% |
| Net income | $-11.09M | $-12.86M | $-20.55M | $-26.05M | $-32.76M | $-33.94M | $-29.15M | $-29.07M | $-47.91M | $-42.76M |
| Net income growth (YoY) | — | -16.0% | -59.8% | -26.8% | -25.8% | -3.6% | +14.1% | +0.3% | -64.8% | +10.8% |
| Profit margin | — | — | — | — | — | — | — | — | — | — |